Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elacycline individualized treatment TDM observational study
ChiCTR2500095429Phase 4Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of eravacycline in bacterial disease, sponsored by Peking University First Hospital. Primary endpoint: Therapeutic drug concentration (TDM of eravacycline). Planned start Jan 2025; status: not yet recruiting.
02
Drugs
eravacycline
03
Conditions
bacterial disease
Beyond the preview
Go deeper on ChiCTR2500095429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095429.